menu ☰
menu ˟

Bioventus launches hyaluronic acid injectable knee OA product in Taiwan

04 Jan 2016
Bioventus LLC announced its stabilized hyaluronic acid product, indicated for mild to moderate knee osteoarthritis, will enter the Taiwan patient care market, according to a company press release. The hyaluronic acid product, called Durolane, is a no...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.